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Abstract
Background: Headache is a highly prevalent disorder. Irrespective of the headache diagnosis it is
often accompanied with neck pain and -stiffness. Due to this common combination of headache and
neck pain, physical treatments of the cervical spine are often considered. The additional value of
these treatments to standard medical care or usual care (UC) is insufficiently documented.
We therefore wanted to compare the treatment effects of UC alone and in combination with
manual therapy (MT) in patients with a combination of headache and neck pain. UC consisted of a
stepped treatment approach according to the Dutch General Practitioners Guideline for headache,
the additional MT consisted of articular mobilisations and low load exercises.
Due to insufficient enrolment the study was terminated prematurely. We aim to report not only
our preliminary clinical findings but also to discuss the encountered difficulties and to formulate
recommendations for future research.
Methods: A randomised clinical trial was conducted. Thirty-seven patients were included and
randomly allocated to one of both treatment groups. The treatment period was 6 weeks, with
follow-up measurements at weeks 7, 12 and 26. Primary outcome measures were global perceived
effect (GPE) and the impact of the headache using the Headache Impact Test (HIT-6). Reduction in
headache frequency, pain intensity, medication intake, absenteeism and the use of additional
professional help were secondary outcome measures
Results: Significant improvements on primary and secondary outcome measures were recorded
in both treatment groups. No significant differences between both treatment groups were found.
The number of recruited patients remained low despite various strategies.
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Conclusion: It appears that both treatment strategies can have equivalent positive influences on
headache complaints. Additional studies with larger study populations are needed to draw firm
conclusions. Recommendations to increase patient inflow in primary care trials, such as the use of
an extended network of participating physicians and of clinical alert software applications, are
discussed.
Trial registration number: NCT00298142
Background
Headache is a highly prevalent disorder with an important
impact on society and on the individual sufferer [1]. Irre-
spective of the headache diagnosis it is often accompanied
with neck pain and movement stiffness [2]. This combina-
tion of clinical signs occurs frequently in Tension-Type
Headache (TTH), Migraine and Cervicogenic Headache
(CEH), which are among the most prevalent headache
types in primary care [3,4].
Patients with headache and neck pain or -stiffness are
often referred for physical cervical spine treatment, such
as manual therapy (MT) [5]. This consists mainly of spe-
cific joint mobilisations of the cervical spine in combina-
tion with exercise therapy to strengthen neck muscles and
to improve active stability of the cervical motion seg-
ments. Various randomised clinical trials (RCTs) and sys-
tematic reviews demonstrate potential positive effects of
this approach for different headache types [6-9].
Clinical guidelines for the medical/pharmaceutical treat-
ment of headaches in primary care are available [10,11].
These guidelines provide diagnostic and therapeutic algo-
rithms and stepped treatment plans for the most common
headache types. The Dutch General Practitioners Guide-
line recommends a reserved attitude towards the prescrip-
tion of physio- or manual therapy since the findings in
literature are not conclusive [10]. The MIPCA guideline
(Migraine In Primary Care Advisors) recommends physi-
cal therapy whenever a headache patient experiences neck
stiffness [5,11]. The European Headache Federation sug-
gest that physio- or manual therapy can be beneficial in
some tension type headache patients, in this way giving
some recommendation but not a firm one [4].
These diverse recommendations illustrate that the addi-
tional value of physical and manual therapy to usual care
in patients with headache is insufficiently documented.
The aim of our study was to compare treatment effects of
two primary care interventions, being the usual care (UC)
and MT adjuvant to UC (UCMT).
Methods
Study design
We conducted a randomised clinical trial with blinded
assessment and unblinded treatment, with a follow-up
period of 52 weeks. We currently present the results of
both treatment groups till the follow-up measurements of
26 weeks. The entire protocol is described in detail else-
where [12] and was registered in clinicaltrials.gov (Clini-
calTrials.gov identifier: NCT00298142). Approval for this
study was obtained from the Medical Ethics Committees
of the University Hospital of the Vrije Universiteit Brussel
(UZ Brussel) and of the University Hospital of Antwerp
(UZA).
We present a summary of the essential parts of the study
design for the present article.
Patients
Recruitment
Patients were recruited at general practitioners (GP's)
offices, from outpatient clinics of the neurology depart-
ment of the university hospitals UZ Brussel and UZA and
via advertisements.
All participating medical doctors (GP's and neurologists)
were contacted and informed personally about the study
goals and protocol. Additional information was provided
on an informative website [13] which included a link to
an online eligibility screenings procedure, allowing easy
referral of potential participants.
The advertisements (on leaflets and internet forums) con-
tained a web link to a recruitment website [14]. On this
site detailed information about the study was provided,
followed by an online eligibility screenings procedure.
In- and exclusion criteria
Dutch speaking patients with a combination of recurrent
headache and neck pain since minimum two months and
at least twice a month with an active help-request (such
headache burden that undergoing treatment is consid-
ered) were included. They had to be at least 18 years old
and willing to participate.
Patients were excluded in case of cluster headache or
trigeminal neuralgia, peripheral neuropathies and co-
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morbidity of chronic musculoskeletal disorders. Patients
were also excluded in case of rheumatoid arthritis, Down
syndrome and/or a history of surgery of the cervical region
and in case of pregnancy. The presence of red flags for
headache (warning signs for serious causes of the head-
ache) was an extra exclusion criterion.
To avoid patients with treatment preferences, we excluded
patients who received MT treatment for their headache
during the last 12 months or patients whose prescribed
medication was changed during the last two months.
The included headache types are migraine, TTH and CEH,
as these are among the types of headache most frequently
seen in general practice [4]. For migraine and TTH the cri-
teria of the International Headache Society (IHS) were
used [15], for CEH we used the criteria of the Cervicogenic
Headache International Study Group (CHISG) [16].
For those patients responding to the advertisements, a
Headache Impact Test (HIT-6, version with 6 questions)
score of at least 56 points was required for inclusion, as
from this critical point, the HIT-6 scoring advises the
patient to contact his/her GP in order to start a treatment.
All subjects signed a written informed consent prior to
enrolment and prior to the baseline measurements. The
informed consent was formulated according to the guide-
lines of the Medical Ethics Committee and contained,
among others, specific information on the content of both
treatment arms and the random allocation.
Baseline measurements
Participants completed a diagnostic headache question-
naire [17]. Doing so, a systematic inventory is made of
headache characteristics such as the localisation of the
headache, pain intensity, frequency and duration of head-
ache attacks. The completed questionnaires were retro-
spectively and independently screened by two raters
(WDH and HC). Consequently a consensus diagnosis for
each patient was made.
The Headache Impact Test (HIT-6) is used to measure the
impact of the headache on the activities of daily living
[18]. Headache related absenteeism and medical con-
sumption (medication and health care contacts) of the
last month are recorded retrospectively.
All questionnaires could be completed online or on
paper.
Randomisation and blinding
Randomisation was performed using blinded envelopes
with a pre-stratification for the headache diagnosis. Pre-
stratification was used to avoid the risk that patients of
one headache type are allocated to one particular treat-
ment group.
Subjects were randomly allocated to one of the two treat-
ment groups after baseline measurements. The informa-
tion of the completed questionnaires remained concealed
ensuring blinded assessment.
Also for the follow-up measurements the rater remained
blinded, as the online version was completed by the par-
ticipating patients themselves, the paper versions were
inserted in the computer software by an independent
blinded rater.
Follow-up measurements, primary and secondary outcome 
measures
Follow-up measurements were planned after 7, 12 and 26
weeks.
Global Perceived Effect (GPE) and the HIT-6 score were
the primary outcome measures.
The GPE was measured using a 7 point scale, with scores
ranging from 'completely recovered' to 'worse than ever'
[18]. The score is dichotomised by labelling those subjects
who perceive their headache complaints as 'completely
recovered' or 'much improved' as responders. Those who
rate their improvement as 'little improvement', 'no
change, slightly worse, much worse and worse than ever'
are labelled as non-responders.
Reduction in headache frequency, pain intensity, medica-
tion intake, absenteeism and headache related health care
contacts were secondary outcome measures and were col-
lected via a questionnaire.
Interventions
The UCMT group received treatment during 6 weeks. It
consisted of a combination of spinal mobilisations and
low-load stabilising exercise therapy, following the proto-
col described by Jull et al[6]. A maximum of 12 sessions
(twice a week over a period of 6 weeks) was provided.
Each session lasted approximately 30 minutes.
To standardise MT treatment, all participants received a
letter containing general recommendations for treatment,
based on the available evidence [6,7], which was to be
handed over to the therapist. Spinal mobilisations consist
of low and/or high-velocity cervical joint mobilization
techniques. Each therapist can decide which techniques of
choice are selected for the treatment based on his own
clinical skills and the patient's situation. Therapeutic exer-
cises consist of low-load endurance exercises, more pre-
cisely cranio cervical flexion exercises.
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To standardise UC, the protocol from the Dutch College
of GPs was used as a guideline [10]. It consists of a stepped
treatment approach. It has a part with patient education
and treatment steps. In the treatment part, non-pharma-
ceutical as well as pharmaceutical interventions (prophy-
lactic and attack medication) are described. The GP
decides what therapeutic step needs to be taken based on
the situation and history of the patient, e.g. by evaluating
the effect of previously taken medication.
Data reduction and analysis
All data were analyzed using the SPSS 12.0 for Windows.
Normality was checked via the Kolmogorov-Smirnov test.
Differences between both treatment groups at baseline
and follow-up measurements were analysed using Chi-
square statistics for categorical variables. For continuous
variables, comparisons between both groups baseline
were made using an independent samples T-test. Compar-
isons between both groups at the follow-up measure-
ments were made using a two-factor repeated measures
ANOVA (group × time). Baseline values were included as
the first follow-up measurements. Differences between
successive measurements within a treatment group were
analysed using a one factor repeated measures ANOVA.
Significance value for all tests was set at p < .05.
Based on sample size calculations, a total of 93 subjects in
each group was set as a target (significance level: p < 0.05,
event rate in the UC group 0.50 and in the UCMT 0.70,
power: 80% and an equal amount of subjects in both
treatment groups).
The number of responders and non-responders was com-
pared. The results of all subjects were analysed, regardless
of their treatment adherence (intention-to-treat analysis).
Differences of means and corresponding confidence inter-
vals are displayed.
Results
Patient recruitment
Patients were recruited from February 2006 till June 2007.
Figure 1 displays a flow chart of the study trajectory. In
total 37 subjects were recruited. Retrospective analysis of
the headache diagnosis questionnaire revealed 10
patients with Migraine, 23 with TTH, two with CEH and
two with a combination of headaches.
Baseline comparisons of both groups
Baseline headache characteristics of both groups are dis-
played in table 1. No significant differences were found
between both groups.
Treatment content
Medication intake of both treatment groups is graphically
displayed in figure 2. Subjects from the UC group use
more NSAIDs and triptans (both available on prescrip-
tion). This difference was not statistically significant.
In table 2 the use of headache related health care contacts
per provider is displayed. The GP and pharmacist are the
most commonly visited health care providers.
In the UCMT group, 10/18 subjects actually visited a man-
ual therapist after referral. The average number of visits
was 8.6 at week 7. Between week 7 and 12, an average of
2 additional visits is reported.
Primary outcome measures
The number of responders, derived from the GPE, is not
significantly different between the two treatment groups.
The HIT-6 score is significantly reduced at each point
compared to baseline in both treatment groups. There
were no significant differences between both treatment
groups of follow-up measurements (table 3).
Secondary outcome measures
Headache intensity decreased in both treatment groups.
Significant differences are flagged in table 4. Only within
group differences were found.
The number of subjects where the headache frequency
decreased with 50% is displayed in table 4. There were no
significant differences between both groups.
Discussion
We compared two treatment regimens for the treatment of
patients with the combination of headache and neck pain
in primary care. The two treatments being investigated
were the GP treatment alone and in combination with
manual therapy. The required number of patients could
not be obtained within the timeframe that was foreseen
for the entire project. Therefore the study was terminated
prematurely.
The headache complaints evolved in both groups in posi-
tive sense such as a significant reductions in HIT-6 score
and average headache intensity of the last four weeks. No
significant differences between both treatment groups of
follow-up measurements were found.
Due to the low number of recruited patients all our results
should be interpreted cautiously. Despite this low number
of participants, however, we report our results as the
design of the study was published [12] and registered in a
trial database [19]. By publishing the results of less suc-
cessful trials, positive publication bias can be avoided and
the results can be included in systematic reviews and
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Flow chart of subjects participation throughout trialigure 1
Flow chart of subjects participation throughout trial. PT: Physiotherapy; MT: Manual therapy, HIT: Headache Impact 
Test; UC: Usual Care; UCMT: Usual Care plus Manual Therapy.
Flyering/  Outpat ient  Neurology Clinics General Pract it ioners 
I nternet  
Referred pat ients (n= 24)  Hits site:  + / -  1900 Referred pat ients  
Referred pat ients (n= 39)  Exclusion (n= 4)  Exclusion (n= 3)  
Exclusion (n= 23)  low headache frequency (n=  
2) , no com binat ion of headache 
and neck pain (n= 1) , PT in last  
year (n= 2) , Medicat ion 
changed during last  3 m onth 
(n= 3) , cluster headache 
(n= 1)and com binat ions of the 
abovement ioned 
Not  Dutch-speaking (n= 1) , 
Unwilling to part icipate (n= 2)  Low HI T-6 score (n= 5) , PT in last  year 
(n= 9) , History of neck surgery (n= 2) , 
arthrit is (n=  2) , no combinat ion of 
headache and neck pain (n= 4) , no 
act ive help request  (n= 1) , and 
com binat ions of the abovement ioned 
 
 
Retained n= 20 Retained n= 16 Retained n= 1 
Random ised = 37 
UC g r ou p  UCMT g r ou p  Allocat ion 
  
Allocated to intervent ion (n= 19)  Allocated to intervent ion (n= 18)  
Received allocated intervent ion (n= 18)  Received allocated intervent ion (n= 10)  
Did not  receive allocated intervent ion (n= 1)  Did not  receive allocated intervent ion (n= 8)  
Reasons:  preferred auto m edicat ion (n= 1)  Reasons:  discouraged by physician to 
part icipate (n= 2) , lack of t ime (n= 3) , t ransport  
problem s (n= 2) , previous negat ive experience 
(n= 1)  
Lost  to follow-up 
Week 7 (n= 4)  
Week 12 (n= 4)  
Week 26 (n= 4)  
Give reasons:  no specific inform at ion obtained 
Discont inued intervent ion:  (n= 0)  
Follow-up 
Analysis Analyzed 
Week 7 (n= 14)  
Week 12 (n= 14)  
Week 26 (n= 14)  
Excluded from  analysis (n= 0)  
 
 
Lost  to follow-up 
Week 7 (n= 1)  
Week 12 (n= 1)  
Week 26 (n= 6)  
Reasons:  no specific inform at ion obtained 
Discont inued intervent ion:  (n= 0)  
 
Analyzed 
Week 7 (n= 18)  
Week 12 (n= 18)  
Week 26 (n= 13)  
Excluded from  analysis (n= 0)  
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meta-analysis. Moreover we propose to analyse causes of
the limited number of included patients and formulate
advice for further research in this domain in primary care.
Study design
The study design was that of a pragmatic trial. In prag-
matic trials the effectiveness of interventions is studied
like they present in daily practice. The subjects can have a
certain heterogeneity, as long as the spectrum of the pop-
ulation to which the studied treatments might be applied
is represented [20,21]. The choice for a pragmatic design
was based on two considerations. First, the observation in
daily practice that patients with the combination of the
clinical signs and symptoms headache and neck pain are
frequently referred for physiotherapy or manual therapy
treatment. An observation which is confirmed in literature
[5,9,22]. Second, the description of beneficial effects of
MT treatment for migraine, TTH and CEH [6,8,9,23]. This
trial differs from previous trials because it investigates the
additional value of MT as an adjuvant therapy to the usual
care.
We included three headache types that are most fre-
quently seen in primary care, and that are frequently
accompanied with neck pain. This setup thus reflects daily
practice, as patients from these three headache types can
be exposed to the interventions studied. Taking these
aspects in consideration, we believe the inclusion of more
than one headache type is justified for our purposes.
Unfortunately, the total number of participants remained
far too low to allow subgroup analysis, with subgroups
based on the headache diagnosis.
Group characteristics
The total sample of patients studied here is representative
for the entire headache population with regard to age and
sex distribution [24,25]. The long history of headache
complaints, the high frequency, pain intensity and high
HIT-6 score indicate that the patients in our sample expe-
rienced a great burden of their headache.
Our participating patients were recruited in various ways
(GP's offices, advertisements and outpatient neurology
clinics). Recruitment via advertisements and outpatient
neurology clinics was added to increase the number of
participants [12]. Based on the exclusion and inclusion
criteria and by means of a diagnostic questionnaire, com-
plemented with the HIT-6, we have made an inventory of
Table 1: Baseline characteristics and differences between both treatment groups
UC (n = 19) UCMT (n = 18) Sign.
Gender (M/F Ratio) 3/16 6/12 ns
Age (years, mean ± SD) 43.32 y ± 14.02 y 43.11 y ± 15.01 y ns
Headache frequency (n)
Daily 15 18 ns
Location Headache (n)
Bilateral 8 6 ns
Bilateral dominant side 3 4 ns
Unilateral shifting 7 3 ns
Unilateral side locked 2 6 ns
Headache history
> 1 year (n) 15 18
Specification of headache duration (years; mean ± SD) 12.50 y ± 12.21 y 13.00 y ± 8.05 y ns
Neck Pain Present (n) 18 16 ns
HIT-6 score (mean ± SD) 61.26 p ± 6.65 p 62.56 p ± 7.6 p ns
Average Pain Intensity (VAS [mm]; mean ± SD)
HA 4 weeks 67.64 ± 16.05 70.87 ± 20.16 ns
HA 3 months 66,26 ± 18,58 65.88 ± 18.38 ns
NP 3 months 45.67 ± 20.90 44.53 ± 20.23 ns
SP 3 months 19.11 ± 24.27 20.59 ± 20.07 ns
Numbers represent the proportion of the entire group which has a certain characteristic, unless specified otherwise. UC: Usual Care, UCMT: 
Usual Care plus Manual therapy, HIT-6: Headache Impact Test, 6 items (scores can range from 36-78 points), HA: Headache, NP: Neck Pain, SP: 
Shoulder Pain. VAS: Visual Analogue Scale (0 mm - 100 mm [0 = no pain; 100 = unbearable pain]), Sign.: Significant. ns: not significant (p > .05)
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their headache characteristics and we presented a detailed
description of their headache features. In all subjects a
headache diagnosis was made based on responses to the
questionnaire and using the revised IHS criteria for
migraine and TTH [15] and the CHISG criteria for CEH
[16]. Diagnoses were assessed independently, and in case
of disagreement a consensus diagnosis was reached after
discussing the case.
Treatment effects
We were unable to demonstrate differences in treatment
effects between both treatment groups at the follow-up
measurements (week 7, 12 and 26). Both groups evolved
positively, despite different accents in the treatment plan.
E.g. the UC group received more medication on prescrip-
tion. If confirmed in studies with larger patients samples
this could indicate a potentially reduced risk for side
effects of medication (e.g. gastro-intestinal bleedings) in
the UCMT than in the UC group.
Comparison of medication intake at baseline, week 7, week 12 and week 26Figure 2
Comparison of medication intake at baseline, week 7, week 12 and week 26. No significant differences between 
both treatment groups were found (Chi-square statistics). Combi: Combined preparation, e.g. of paracetamol and caffeine, 
NSAIDs: Non Steroidal Anti-inflammatory Drugs. UC: Usual Care, UCMT: Usual Care plus Manual Therapy.
Table 2: Overview of numbers of headache related health care contacts of both treatment groups
Week 7 Week 12 Week 26
UC
(n = 18)
UCMT
(n = 14)
UC
(n = 18)
UCMT (n = 14) UC
(n = 13)
UCMT (n = 14)
MT 1 10 2 7 1 /
GP 8 4 4 2 2 2
Neurologist / 1 1 / / 1
Pharmacist 6 4 5 2 6 /
Psychologist 1 2 / 2 / /
Other / 1 2 1 1 /
The number of people who contacted a health care provider is displayed. The total number of participants is displayed at the top of each column.
UC: Usual Care, UCMT: Usual Care plus Manual therapy. MT: Manual Therapy, GP: General Practitioner. The health care providers reported under 
the section 'other' are an osteopath, an orthomolecular doctor, a massage therapist (Shiatsu and Thai) and an internist.
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Both treatment regimens appear to be equivalent. None-
theless, further research with larger patients samples is
needed to clarify potential differences between both
groups.
For future trials we recommended to use a headache diary.
This can provide more complete and day by day informa-
tion allowing a more profound recording of outcome
measures.
Treatment adherence and content
Of the original 18 patients in the UCMT group only 10
actually followed the suggested treatment. Of the remain-
ing eight, five reported practical implications of MT treat-
ment: lack of time to attend the therapeutic sessions
regularly or transport difficulties. One patient was disap-
pointed to be allocated in this treatment group, based on
previous negative experiences with similar therapies. Two
patients who entered the trial via the advertisements, were
discouraged by their own physician to participate in the
trial, without further specification of their arguments. We
believe this is hard to avoid in the setup of a research pro-
tocol. As suggested by Vernon et al., maybe some kind of
remuneration for participation could be useful to antici-
pate [26].
Based on the reports of the treating therapists, which
described the treatment that was delivered, we have strong
indications that the suggested treatment strategy in the
UCMT group (a combination of spinal mobilisations and
low load exercises) was actually followed. The average
number of treatments was 8.6. This lies within the range
of the number of treatments in studies using the same
therapeutic approach [6,7]. No previous training period
with the therapists was held due to practical reasons and
to avoid withdrawal of therapists participation because of
the time investment. For future research a training period
with all participating therapists can be useful to standard-
ise the delivered treatment even more.
Regarding the medication intake of patients, we see that
the UC group received more medication for which a pre-
scription is required, whereas in the beginning they
mainly used over-the-counter medication. Subjects in this
group receive more NSAIDS and triptans than the UCMT
group and more than at baseline. This indicates that the
stepwise pharmaceutical approach as described in the pro-
posed guideline is followed by the GP's. The GP's who
actually participated by referring patients were probably
positively biased, knew guidelines and understood their
potential in improving patient care. No side or adverse
effects were reported by the participants, but more pro-
active monitoring of potential adverse effects in either
treatment arms is recommended for future trials.
Patient enrolment
Sufficient patient enrolment is a key issue in every clinical
trial. Recruitment difficulties are also reported by Vernon
et al [26]. Apparently chronic headache patients are diffi-
cult to recruit in primary care settings and difficult to
maintain within the boundaries of a treatment protocol.
Our disappointing enrolment is probably the result of
multiple factors.
Only half of the contacted physicians actually referred
patients for the study, and most of them referred only one
patient. Some of the documented reasons for insufficient
participation of physicians are lack of time, difficulties
with complex enrolment procedures, insufficient knowl-
edge and awareness of the trial, concerns about the impact
of trial participation on the doctor-patient relationship or
about the loss of professional autonomy [27-29]. One rec-
ommends intrinsic motivation, frequent reminders and
practically feasible study protocols to achieve a more suc-
cessful participation of physicians.
We contacted all physicians personally (first by phone,
followed by at least one visit). The research protocol was
explained, the research question and its clinical relevance
were discussed. All physicians recognised the frequently
Table 3: Differences in primary outcome measures
Variable Treatment Group Follow-up week 7 Follow-up week 12 Follow-up week 26
Responders/Non responders (GPE) UC 6/12 6/12 7/6
UCMT 5/9 5/9 6/8
Diff Proportion 3% 3% 11%
HIT-6 score (points) UC 60.10 ± 5.55* 58.50 ± 4.62* 56.80 ± 6.46*
mean ± SD UCMT 57.93 ± 4.58* 56.00 ± 6.95* 55.21 ± 9.75*
Mean Diff 2.17 2.50 3.54
CI -2.12; 6.46 -2.74; 7.74 -5.76; 8.94
GPE: Global Perceived Effect; HIT-6: Headache Impact Test, 6 items (scores can range from 36-78 points), CI: Confidence interval; Diff: Difference 
between groups; UC: Usual Care; UCMT: Usual care plus Manual Therapy.
*: significant within group difference compared to value at baseline (Repeated Measures ANOVA, sign. level: p < .05)
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occurring and challenging combination of headache and
neck pain. The clinical value of the research question was
stressed as well as the importance of physician coopera-
tion for clinical studies in primary care. These aspects are
recommended to enhance the physicians motivation and
to gain their commitment [29,30]. We provided addi-
tional study information on websites which contained
also online enrolment procedures, making the referral
procedure as easy as possible. Regularly reminder e-mails
were sent to keep their attention with the study. Despite
our efforts the number of referred and enrolled patients
remained discouragingly low.
For future research we recommend the development of a
far more extensive network of physicians, taking into
account that only a limited number will actually partici-
pate and refer patients. For instance, Van der Wouden et
al. found that only 30% of all contacted GP's actually par-
ticipated in studies with an interventional setup [31].
Table 4: Differences in secondary outcome measures
Variable Treatment Group Follow-up week 7 Follow-up week 12 Follow-up week 26
VASHA3M (mm)
Mean ± SD
UC / 45.14 ± 25.71 38.43 ± 27.60
UCMT / 44.12 ± 24.15* 37.11 ± 26.52*
Mean Diff / 0.92 1.32
CI / -25.92; 27.76 -28.27; 30.91
VASHA4W (mm)
Mean ± SD
UC 40.78 ± 29.32* 36.78 ± 23.59* 32.11 ± 28.20*
UCMT 40.73 ± 27.87* 28.00 ± 22.89* 33.18 ± 29.31*
Mean Diff 0.05 8.78 -1.07
CI -26.88: 26.98 -13.14; 30.69 -28.29; 26.15
VASHANOW (mm)
Mean ± SD
UC 31.91 ± 29.37 34.09 ± 28.19 13.55 ± 24.23
UCMT 15.33 ± 24.33 15.25 ± 27.76 19.92 ± 29.09
Mean Diff 16.57 18.84 -6.37
CI -6.73; 39.88 -5.44; 43.12 -29.71; 16.97
VASNP3M (mm)
Mean ± SD
UC / 24.29 ± 21.37* 24.43 ± 20.70*
UCMT / 28.67 ± 18.26 16.11 ± 18.56
Mean Diff / -4.38 8.32
CI / -25.63; 16.87 -12.77; 29.40
VASNPNOW (mm)
Mean ± SD
UC 23.00 ± 29.18* 16.86 ± 22.39* 14.71 ± 20.23*
UCMT 15.44 ± 22.02 18.56 ± 27.97 8.44 ± 15.36
Mean Diff 7.66 -1.70 6.27
CI -19.83; 34.94 29.51; 26.11 -12.77; 25.31
50% Reduction HA Frequency. Number achieved/not 
achieved
UC 12/5 11/6 12/1
UCMT 12/2 11/3 12/2
Diff Prop 15% 14% 6%
Absenteeism (number absent/not absent) UC 1/15 1/14 2/9
UCMT 0/13 1/12 2/11
Diff Prop 6% 1% 3%
VASHA3M: Average Headache Intensity of the last three months, VASHA4W Average Headache Intensity of the last four weeks, VASHANOW: 
Headache Intensity at the moment of testing
VASNP3M Average Neck Pain Intensity of the last three months, VASNPNOW Neck Pain Intensity at the moment of testing; Diff: difference 
between groups; Prop: proportion
HA: Headache. VAS: 100 mm Visual Analogue Scale (0 mm: no pain; 100 mm: unbearable pain)
*: significant within group difference compared to value at baseline (repeated measures ANOVA, sign. level: p < .05)
UC: Usual Care; UCMT: Usual Care plus Manual Therapy; Diff
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The use of software applications which are incorporated
in the patients electronic health record should be consid-
ered. Embi et al. developed and used a Clinical Trial Alert
System which increased the physicians participation and
patient enrolment significantly [28,32].
In our opinion, the fear of physicians to lose professional
autonomy was a major issue. Clinicians have treatment
preferences, and randomised study protocols require
them to take a step back from daily routine, or even to pre-
scribe a treatment they do not fully support. This can
result in selective participation and referral of patients.
Only those patients who do not fit in the regular schema
or in who the regular schema was not successful are con-
sidered for referral to participate in the study.
Not only clinicians, but also patients have treatment pref-
erences. Current legislation demands that patients are a
priori informed in detail about the study purposes and
procedures, by means of a written informed consent.
Patients who prefer one of the treatment strategies in the
study protocol are potentially biased or risk to be de-moti-
vated when they are not allocated to the group they
wanted to be allocated to. This might be one of the expla-
nations for a number of not returned follow-up question-
naires and dropouts.
Treatment preferences of both physicians and patients can
thus lead to insufficient enrolment and dropouts. The
number of dropouts was equivalent in both treatment
groups, so these factors have played equally in both
groups.
As a remedy, the use of observational studies should be
considered in future studies. E.g. Pfeiffer et al. used a pro-
spective cohort study to avoid conflicts with physicians
routine and treatment preferences of both physicians and
patients [33].
If an observational study protocol results in a larger
patient sample, the analysis of subgroups can be per-
formed. The treatment that has been followed can be
inserted in the analyses as independent variable.
Bell-Syer et al. recommend the use of wide inclusion crite-
ria in the early screening of potential subjects [30]. To
avoid biased patients we excluded patients who received
MT treatment for their headaches during the last 12
months or patients whose prescribed medication was
changed during the last two months. In this patient pop-
ulation these can be too strict exclusion criteria. In future
research this exclusion criteria can be formulated less
strict, which will probably result in a greater enrolment.
Conclusion
The headache complaints of both treatment groups
evolved positively. We were unable to demonstrate differ-
ences between both treatment groups. Future studies with
larger patients samples are needed. To achieve a higher
number of patients in future studies we recommend the
use of an extensive network of participating physicians,
the use of software applications incorporated in patients'
electronic health record. The use of observational instead
of randomised study protocols should be considered.
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